What is a constipation severity scale?

Constipation severity scales quantify symptom burden across multiple domains, allowing objective comparisons over time and between patients. Common validated scales include: Wexner/Cleveland Clinic Constipation Score (0–30), Patient Assessment of Constipation Symptoms (PAC-SYM), and Constipation Assessment Scale (CAS). The Wexner score is most commonly used in colorectal surgery settings.

How does the Wexner score differ from Rome IV functional constipation criteria?

Rome IV criteria are diagnostic (2+ symptoms in more than 25% of defecations for 6 months, no loose stools without laxatives, insufficient criteria for IBS). The Wexner score is a severity measure — it quantifies symptom burden across 8 domains with numerical scores. Patients can meet Rome IV criteria with varying Wexner severity (mild to severe). Both tools are complementary.

What is pelvic floor dysfunction constipation, and how does Wexner apply?

Pelvic floor dyssynergia (obstructed defecation) occurs when the puborectalis and external anal sphincter contract instead of relax during defecation straining. Patients typically have high Wexner subscores for difficulty, incomplete evacuation, time per attempt, and need for digital assistance. Diagnosis requires anorectal manometry showing paradoxical sphincter contraction plus failed balloon expulsion test.

What is biofeedback therapy for constipation?

Biofeedback therapy retrains the pelvic floor muscles to relax appropriately during defecation. Using anorectal manometry or surface EMG sensors, patients learn to coordinate straining effort with puborectalis relaxation. 5–6 sessions over 3 months are typical. Evidence: Rao et al. (Am J Gastroenterol 2007) showed 70–80% response rate — superior to laxatives alone for dyssynergia-related constipation.

What is the colonic transit study for constipation?

Colonic transit study (Sitz mark study) involves swallowing radiopaque markers and taking abdominal X-rays at 24, 48, and 120 hours. Normal: 80% of markers expelled by 120 hours. Delayed transit: more than 5 markers remaining at 120 hours indicates slow-transit constipation. Transit studies distinguish slow-transit constipation from pelvic outlet obstruction (markers reach rectum but are not expelled).

What is linaclotide, and is it effective for chronic constipation?

Linaclotide (Linzess) is a guanylate cyclase-C agonist FDA-approved for chronic idiopathic constipation (145 mcg daily) and IBS-C (290 mcg daily). It increases intestinal fluid secretion and accelerates transit. Multiple RCTs show significant improvement in complete spontaneous bowel movements, straining, stool consistency, and Wexner score compared to placebo. Side effect: diarrhea in approximately 20% of patients.

What medications can cause constipation?

Common medication causes of constipation: opioids/opiates (most potent cause — consider methylnaltrexone or naloxegol for opioid-induced constipation), iron supplements, calcium channel blockers (verapamil most), anticholinergics (tricyclics, antihistamines, bladder medications), aluminum-containing antacids, and NSAIDs. Review all medications before attributing constipation to a functional cause.

When is surgery considered for chronic constipation?

Surgery is a last resort for chronic constipation after exhausting medical treatment (fiber, PEG, secretagogues, biofeedback). Total colectomy with ileorectal anastomosis is the standard surgical option for confirmed severe slow-transit constipation (Wexner score typically above 20) refractory to all medical therapy. Pelvic floor dyssynergia must be excluded or treated first — surgery worsens outcomes in dyssynergia.

Online Medical Tools — Wexner Constipation Score

Printed on 9/3/2026

For informational purposes only. This is not medical advice.

Gastroenterology

Wexner Constipation Score

The Wexner Constipation Score is a structured symptom score used to quantify chronic constipation severity over multiple domains including bowel frequency, evacuation difficulty, incomplete evacuation, assistance needs, and symptom duration.

Formula: Wexner score is the sum of 8 symptom domains, each 0-4 (total range 0-30).

Frequency of bowel movements

Difficulty/painful evacuation effort

Sensation of incomplete evacuation

Abdominal pain with evacuation attempts

Time per evacuation attempt

Need for assistance (laxatives/enemas/digital)

Failed attempts for evacuation per day

Duration of constipation history

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Score 8 clinical parameters over the past month

Score 8 parameters over the past month: bowel movement frequency, straining/difficulty with defecation, sensation of incomplete evacuation, abdominal pain with evacuation, time spent per attempt, need for digital assistance or enema, unsuccessful defecation attempts per 24 hours, and duration of constipation symptoms.

Sum the 8 domain scores (0–30 total)

Each of the 8 parameters is scored 0–4 based on frequency (0=never, 4=always). Sum all 8 scores for a total ranging from 0–30.

Interpret severity and guide management escalation

Score 0–8 = normal; 9–14 = mild constipation; 15–20 = moderate constipation; above 20 = severe constipation. Scores above 15 warrant thorough workup including colonic transit studies and anorectal manometry. Scores above 20 may require surgical consultation.

Who Uses the Wexner Constipation Score

Colorectal Surgery Constipation Severity Assessment

Colorectal surgeons

Quantify constipation severity before surgical interventions (sacral nerve stimulation, colectomy, biofeedback). The Wexner score was developed specifically for colorectal surgery populations and is validated in that clinical context.

Pelvic Floor Dysfunction Evaluation

Pelvic floor physical therapists

Assess constipation severity in patients with suspected pelvic floor dyssynergia. High Wexner scores combined with difficulty with defecation and incomplete evacuation suggest pelvic outlet obstruction rather than slow-transit constipation.

Pre-Surgical Biofeedback Candidacy Assessment

Surgeons

Document baseline constipation severity before recommending biofeedback therapy. A moderate-to-high Wexner score (15+) with features of pelvic floor dyssynergia supports biofeedback as first-line treatment before surgical options.

Clinical Trial Laxative and Procedure Outcomes

Researchers

Use as a validated primary or secondary endpoint in clinical trials for constipation treatments — laxatives, prucalopride, sacral nerve stimulation, or surgical procedures. Wexner score change is a clinically meaningful outcome measure.

Medical Management Monitoring in Chronic Constipation

Gastroenterologists

Track Wexner score response to osmotic laxatives (PEG 3350), secretagogues (linaclotide, lubiprostone), or prokinetics (prucalopride). Score reduction of 5+ points typically indicates clinically meaningful improvement.

Pro Tips

Wexner was validated for colorectal surgery patients — use in that context

The Wexner Constipation Scoring System was developed and validated by Agachan et al. (1996) specifically for colorectal surgery patients. It is best suited for functional constipation and pelvic outlet obstruction evaluation rather than acute or transient constipation.

Score above 15 warrants formal physiological workup

A Wexner score above 15 indicates significant constipation that warrants thorough evaluation: colonic transit study (radiopaque markers or scintigraphy), anorectal manometry, and balloon expulsion test. This workup distinguishes slow-transit constipation from pelvic floor dyssynergia — treatments differ substantially.

Rome IV functional constipation criteria: 2+ symptoms for 6+ months

Rome IV criteria for functional constipation: 2 or more of the following in more than 25% of defecations for at least 6 months: straining, lumpy/hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, manual maneuvers needed, fewer than 3 spontaneous bowel movements per week. The Wexner score quantifies these same domains.

Anorectal manometry diagnoses pelvic floor dyssynergia

Pelvic floor dyssynergia (paradoxical puborectalis contraction during defecation straining) is diagnosed by anorectal manometry showing paradoxical sphincter contraction during straining, combined with a failed balloon expulsion test (unable to expel 50mL balloon). This is a common cause of high Wexner scores that does not respond to laxatives alone.

Biofeedback is first-line for pelvic floor dyssynergia — 70–80% response

Biofeedback therapy is first-line treatment for pelvic floor dyssynergia with 70–80% response rates (Rao et al., 2007). Patients learn to relax the puborectalis and external anal sphincter during defecation straining. 5–6 sessions are typically required. Biofeedback should be tried before sacral nerve stimulation or surgery.

PEG 3350 is first-line osmotic laxative; docusate has poor evidence

Polyethylene glycol 3350 (MiraLax, Movicol) is first-line for functional constipation — superior to lactulose in multiple trials (Ford et al., Cochrane 2011). Docusate (stool softener) has weak evidence and is not recommended as monotherapy for chronic constipation. Starting with PEG before escalating to secretagogues is appropriate.

Linaclotide and lubiprostone are FDA-approved for chronic constipation

FDA-approved secretagogues for chronic idiopathic constipation: linaclotide (Linzess, 145 mcg daily) and lubiprostone (Amitiza, 24 mcg twice daily). Both increase intestinal fluid secretion and reduce Wexner score. Indicated when PEG fails. Linaclotide is also approved for IBS-C.

Sacral nerve stimulation (SNS) for refractory slow-transit constipation

Sacral nerve stimulation (neuromodulation) is FDA-approved for refractory chronic constipation. It modulates neural pathways to the colon and pelvic floor. Wexner scores above 20 refractory to medical therapy may warrant SNS evaluation. Success rates of 50–70% in properly selected patients.

Fiber intake target: 25–38 g/day with gradual increase

Dietary fiber target is 25 g/day for women and 38 g/day for men. Gradual increase prevents gas and bloating — add 5 g/day per week. Both soluble fiber (psyllium, oats — softens stool) and insoluble fiber (wheat bran, vegetables — adds bulk) are beneficial. Adequate fluid intake (8–10 cups/day) is essential to prevent fiber from worsening constipation.

Colectomy with ileorectal anastomosis for severe refractory slow-transit constipation

Total colectomy with ileorectal anastomosis is a last-resort surgical option for severe, refractory slow-transit constipation (Wexner scores typically above 20) after all medical and biofeedback treatments have failed and slow transit confirmed by transit studies. Patient selection is critical — pelvic floor dyssynergia must be excluded or treated first.

Common Questions About Your Results

The Wexner score cannot distinguish slow-transit constipation from pelvic floor dyssynergia (outlet obstruction). These conditions have different treatments — laxatives for slow transit, biofeedback for dyssynergia. A high Wexner score (especially with high difficulty, incomplete evacuation, and long time per attempt) warrants anorectal manometry and balloon expulsion test before escalating treatment.

The Wexner score quantifies symptom burden but does not identify etiology, alarm features, or contributing medications. It should always be interpreted alongside a complete bowel history, medication review, physical examination (including digital rectal exam for resting and squeeze tone), and red flag screening (bleeding, weight loss, family history of CRC). The score guides severity — the history guides diagnosis.

Evidence-Based Methodology

Wexner Constipation Scoring System published by Agachan et al. (Dis Colon Rectum 1996) from 232 patients at Cleveland Clinic. Internal consistency and face validity established in constipation and fecal incontinence populations. Cutoff 9: distinguishes normal from constipated patients. Validated in multiple colorectal surgery centers internationally. Rome IV criteria for functional constipation: Mearin et al. (Gastroenterology 2016). Biofeedback for pelvic floor dyssynergia: Rao et al. (Am J Gastroenterol 2007) — 70–80% success. PEG 3350 first-line evidence: Ford et al. (Cochrane 2011).

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Higher scores represent more severe constipation burden and may support escalation of evaluation/treatment strategy.

When to Use This Tool

Use in chronic constipation assessment, specialist referral baseline documentation, and longitudinal symptom monitoring.

Limitations

The score is symptom-based and subjective, and should be interpreted with bowel history, medication review, and alarm symptom assessment.

For related assessments, see Bristol Stool Scale, Water Intake and Protein Intake.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Gastroenterology

Bristol Stool Scale

Classify stool form using the Bristol Stool Scale to support constipation/diarrhea pattern assessment and symptom tracking.

Open Nutrition

Water Intake

Calculate recommended daily water intake based on body weight and activity level, with hydration targets in liters and cups.

Open Nutrition

Protein Intake

Calculate recommended daily protein intake based on body weight, activity level, and fitness goals.

Open Gastroenterology

Rockall Score

Calculate the Rockall score to predict rebleeding and mortality in upper GI hemorrhage. Pre-endoscopy score ≤2: low risk for rebleeding. Post-endoscopy score 0: <5% rebleeding risk.

Open

Frequently Asked Questions

The Wexner Constipation Scoring System (Cleveland Clinic Constipation Score) is a validated 8-item questionnaire developed by Agachan et al. (1996) to quantify chronic constipation severity. It scores 8 domains (bowel frequency, straining difficulty, incomplete evacuation, abdominal pain, time per attempt, need for assistance, failed attempts per day, and duration) each on a 0–4 scale for a total of 0–30.

Score 0–8 = normal bowel function. Score 9–14 = mild constipation — initial medical management appropriate (PEG 3350, increased fiber/fluids). Score 15–20 = moderate constipation — consider formal physiological testing (transit study, anorectal manometry) and prescription medications. Score above 20 = severe constipation — thorough workup including surgical consultation may be indicated.

Chronic constipation assessment includes: (1) Symptom quantification — Wexner score, Rome IV criteria, stool diary with Bristol types. (2) Secondary cause exclusion — thyroid function, calcium, glucose, colonoscopy if alarm features. (3) Physiological testing if moderate-severe — colonic transit study, anorectal manometry, balloon expulsion test, defecography. (4) Medication review (opioids, iron, anticholinergics are common causes).

A Wexner score above 20 indicates severe constipation with significant functional impairment. This severity level warrants comprehensive physiological workup (colonic transit study, anorectal manometry, defecography) if not already performed, trial of prescription agents (linaclotide, lubiprostone, prucalopride), biofeedback if pelvic floor dyssynergia identified, and surgical consultation if medical treatments fail.

Online Medical Tools — Wexner Constipation Score

Wexner Constipation Score

How It Works

Score 8 clinical parameters over the past month

Sum the 8 domain scores (0–30 total)

Interpret severity and guide management escalation

Who Uses the Wexner Constipation Score

Colorectal Surgery Constipation Severity Assessment

Pelvic Floor Dysfunction Evaluation

Pre-Surgical Biofeedback Candidacy Assessment

Clinical Trial Laxative and Procedure Outcomes

Medical Management Monitoring in Chronic Constipation

Pro Tips

Wexner was validated for colorectal surgery patients — use in that context

Score above 15 warrants formal physiological workup

Rome IV functional constipation criteria: 2+ symptoms for 6+ months

Anorectal manometry diagnoses pelvic floor dyssynergia

Biofeedback is first-line for pelvic floor dyssynergia — 70–80% response

PEG 3350 is first-line osmotic laxative; docusate has poor evidence

Linaclotide and lubiprostone are FDA-approved for chronic constipation

Sacral nerve stimulation (SNS) for refractory slow-transit constipation

Fiber intake target: 25–38 g/day with gradual increase

Colectomy with ileorectal anastomosis for severe refractory slow-transit constipation

Common Questions About Your Results

Evidence-Based Methodology

Clinical Content Trust

How to Interpret Your Result

When to Use This Tool

Limitations

Changelog

Related Tools

Bristol Stool Scale

Water Intake

Protein Intake

Rockall Score

Further Reading

A Complete Guide to Gastroenterology and Digestive Health

Frequently Asked Questions